Chemoinformatics and artificial intelligence colloquium: progress and challenges in developing bioactive compounds

11Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report the main conclusions of the first Chemoinformatics and Artificial Intelligence Colloquium, Mexico City, June 15–17, 2022. Fifteen lectures were presented during a virtual public event with speakers from industry, academia, and non-for-profit organizations. Twelve hundred and ninety students and academics from more than 60 countries. During the meeting, applications, challenges, and opportunities in drug discovery, de novo drug design, ADME-Tox (absorption, distribution, metabolism, excretion and toxicity) property predictions, organic chemistry, peptides, and antibiotic resistance were discussed. The program along with the recordings of all sessions are freely available at https://www.difacquim.com/english/events/2022-colloquium/.

Cite

CITATION STYLE

APA

Bajorath, J., Chávez-Hernández, A. L., Duran-Frigola, M., Fernández-de Gortari, E., Gasteiger, J., López-López, E., … Valli, M. (2022). Chemoinformatics and artificial intelligence colloquium: progress and challenges in developing bioactive compounds. Journal of Cheminformatics, 14(1). https://doi.org/10.1186/s13321-022-00661-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free